Blockade of CCK(B) but not CCK(A) receptors before and after the stress of predator exposure prevents lasting increases in anxiety-like behavior: Implications for anxiety associated with posttraumatic stress disorder

Behavioral Neuroscience

Volumn 111, Issue 2, 1997, Pages 435-449

  Adamec, Robert E ^a   Shallow, Tanya ^a   Budgell, John ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR ANTAGONIST; CHOLECYSTOKININ B RECEPTOR ANTAGONIST;

AFFECTIVE NEUROSIS; ANIMAL EXPERIMENT; ANXIETY NEUROSIS; ARTICLE; CAT; CHOLECYSTOKININ BLOOD LEVEL; DISEASE ASSOCIATION; MAZE TEST; NONHUMAN; POSTTRAUMATIC STRESS DISORDER; PREDATION;

AGONISTIC BEHAVIOR; ANIMALS; ANXIETY; AROUSAL; BENZODIAZEPINONES; CATS; DEVAZEPIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCAPE REACTION; FEAR; INDOLES; MALE; MAZE LEARNING; MEGLUMINE; PREDATORY BEHAVIOR; PYRAZOLES; RATS; RECEPTOR, CHOLECYSTOKININ A; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, CHOLECYSTOKININ; RETENTION (PSYCHOLOGY); STARTLE REACTION; STRESS DISORDERS, POST-TRAUMATIC;

EID: 0030938513     PISSN: 07357044     EISSN: None     Source Type: Journal    
DOI: 10.1037/0735-7044.111.2.435     Document Type: Article

References (64)

1. Adamec, R. E. (1991a). Corticotrophin releasing factor: A peptide link between stress and psychopathology associated with epilepsy. Journal of Psychopharmacology, 5, 96-104.
2. Adamec, R. E. (1991b). Partial kindling of the ventral hippocampus: Identification of changes in limbic physiology which accompany changes in feline aggression and defense. Physiology and Behavior, 49, 443-453.
3. Adamec, R. E. (1993a). Lasting effects of FG-7142 on anxiety, aggression and limbic physiology in the cat. Journal of Psychopharmacology, 7, 232-248.
4. Adamec, R. E. (1993b). Partial limbic kindling: Brain, behavior, and the benzodiazepine receptor. Physiology and Behavior, 54, 531-545.
5. Adamec, R. E. (1994a, May). The anxiogenic effects of exposure of rats to natural threat (Cats) in two strains of rat: Effects on behavior in the elevated plus maze and acoustic startle - further support for a model of posttraumatic stress disorder. Paper presented at the annual meeting of the Behavioral Neuroscience Society, Clearwater, FL.
6. Adamec, R. E. (1994b). Modelling anxiety disorders following chemical exposures. Toxicology and Industrial Health, 10, 391-420.
7. Adamec, R. E. (1997). Evidence that NMDA dependent limbic neural plasticity in the right hemisphere mediates stressor induced lasting increases in anxiety-like behavior: A model of limbic plasticity in posttraumatic stress disorder? Manuscript submitted for publication.
8. Adamec, R. E. (in press). Transmitter systems involved in neural plasticity underlying increased anxiety and defense: Implication for understanding anxiety following traumatic stress. Neuroscience and Biobehavioral Reviews.
9. Adamec, R. E., & Morgan, H. D. (1994). The effect of kindling of different nuclei in the left and right amygdala on anxiety in the rat. Physiology and Behavior, 55, 1-12.
10. Adamec, R. E., & Shallow, T. (1993). Lasting effects on rodent anxiety of a single exposure to a cat. Physiology and Behavior, 54, 101-109.
11. Adamec, R. E., Shallow, T., & Budgell, J. (1997). NMDA receptors mediate lasting increases in anxiety-like behavior produced by the stress of predator exposure: Implications for anxiety associated with posttraumatic stress disorder - A psychopharmacological and path analytic study. Manuscript submitted for publication.
12. Adamec, R. E., Stark-Adamec, C., & Livingston, K. E. (1980). The development of predatory aggression and defense in the domestic cat (Fellis catus): I. Effects of early experience on adult patterns of aggression and defense. Behavioral and Neural Biology, 30, 389-409.
13. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
14. Bandler, R., & Depaulis, A. (1990). Midbrain periaqueductal gray control of defensive behavior in the cat and the rat. In A. Depaulis & R. Bandler (Eds.), The midbrain periaqueductal gray matter: Functional, anatomical and neurochemical organization (pp. 175-198). New York: Plenum Press.
15. Bandopadhyay, R., & De Belleroche, J. (1991). Regulation of CCK release in cerebral cortex by N-methyl-D-aspartate receptors: Sensitivity to APV, MK-801, kynurenate, magnesium and zinc ions. Neuropeptides, 18, 159-163.
16. Belcheva, I., Belcheva, S., Petkov, V. V., & Petkov, V. D. (1994). Asymmetry in behavioral responses to cholecystokinin microinjected into rat nucleus accumbens and amygdala. Neuropharmacology, 33, 995-1002.
17. Belzung, C., Pineau, N., Beuzen, A., & Misslin, R. (1994). PD135158, a CCK-B antagonist, reduces "state," but not "trait" anxiety in mice. Pharmacology, Biochemistry and Behavior, 49, 433-436.
18. Benkelfat, C., Bradwejn, J., Meyer, E., Ellenbogen, M., Milot, S., Gjedde, A., & Evans, A. (1995). Functional neuroanatomy of CCK4-induced anxiety in normal healthy volunteers. American Journal of Psychiatry, 152, 1180-1184.
19. Bentler, P. M. (1995). EQS structural equations program manual. Encino, CA: Multivariate Software.
20. Bickerdike, M. J., Marsden. C. A., Dourish, C. T., & Fletcher, A. (1994). The influence of 5-hydroxytryptamine re-uptake blockade on CCK receptor antagonist effects in the rat elevated zero-maze. European Journal of Pharmacology, 271, 403-411.
21. Bíró, H., Sarnyai, Z., Penke, B., Szabó, G., & Telegdy, G. (1993). Role of endogenous corticotropin-releasing factor in mediation of neuroendocrine and behavioral responses to cholecystokinin octapeptide sulfate ester in rats. Neuroendocrinology, 57, 340-345.
22. Blanchard, D. C., Blanchard, R. J., De Padua Carobrez, A., Veniegas, R., Rodgers, R. J., & Shepherd, J. K. (1992). MK-801 produces a reduction in anxiety-related antipredator defensiveness in male and female rats and a gender-dependent increase in locomotor behavior. Psychopharmacology, 108, 352-362.
23. Blanchard, R. J., & Blanchard, D. C. (1989). Antipredatory defensive behaviors in a visible burrow system. Journal of Comparative Psychology, 103, 70-82.
24. Blanchard, R. J., Blanchard, D. C., Agullana, R., & Weiss, S. M. (1991). Twenty-two kHz alarm cries to presentation of a predator, by laboratory rats living in visible burrow systems. Physiology and Behavior, 50, 967-972.
25. Boden, P., & Hill, R. G. (1988). Effects of cholecystokinin and related peptides on neuronal activity in the ventromedial nucleus of the rat hypothalamus. British Journal of Pharmacology, 94, 246-252.
26. Bradwejn, J., & Koszycki, D. (1994). The cholecystokinin hypothesis of anxiety and panic disorder. Annals of the New York Academy of Sciences, 713, 273-282.
27. Byrne, B. M. (1994). Structural equation modelling with EQS and EQS/Windows. London: Sage.
28. Chopin, P., & Briley, M. (1993). The benzodiazepine antagonist flumazenil blocks the effects of CCK receptor agonists and antagonists in the elevated plus-maze. Psychopharmacology, 110, 409-414.
29. Costall, B., Domeney, A. M., Hughes, J., Kelly, M. E., Naylor, R. J., & Woodruff, G. N. (1991). Anxiolytic effects of CCKB antagonists. Neuropeptides, 19(Suppl), 65-73.
30. Crawley, J. N., & Corwin, R. L. (1994). Biological actions of cholecystokinin. Peptides, 15, 731-755.
31. Derrien, M., McCort-Tranchepain, I., Ducos, B., Roques, B. P., & Durieux, C. (1994). Heterogeneity of CCK-B receptors involved in animal models of anxiety. Pharmacology, Biochemistry and Behavior, 49, 133-141.
32. File, S. E., & Wardill, A. G. (1975). Validity of head-dipping as a measure of exploration in a modified hole-board. Psychopharmacology (Berlin), 44, 53-59.
33. File, S. E., Zangrossi, H., Jr., Sanders, F. L., & Mabbutt, P. S. (1993). Dissociation between behavioral and corticosterone responses on repeated exposures to cat odor. Physiology and Behavior, 54, 1109-1111.
34. Harro, J., Pold, M., & Vasar, E. (1990). Anxiogenic-like action of caerulein, a CCK-8 receptor agonist, in the mouse: Influence of acute and subchronic diazepam treatment. Naunyn Schmiedebergs Archives of Pharmacology, 341, 62-67.
35. B receptors mediate the regulation of exploratory behaviour in the rat. European Journal of Pharmacology, 193, 379-381.
36. Harro, J., Vasar, E., & Bradwejn, J. (1993). CCK in animal and human research on anxiety. Trends in Pharmacological Sciences, 14, 244-249.
37. B antagonists on activity in the black/white exploration model of anxiety in mice. Physiology and Behavior, 54, 689-693.
38. Horger, B. A., Elsworth, J. D., & Roth, R. H. (1995). Selective increase in dopamine utilization in the shell subdivision of the nucleus accumbens by the benzodiazepine inverse agonist FG 7142. Journal of Neurochemistty, 65, 770-774.
39. Kim, C., Kim, C. C. Kim, J. K., Kim, M. S., Chang, H. K, Kim, J. Y., & Lee, I. G. (1971). Fear response and aggressive behavior of hippocampectomized house rats. Brain Research, 29, 237-251.
40. Lanaud, P., Popovici, T., Normand, E., Lemoine, C., Bloch, B., & Roques, B. P. (1989). Distribution of CCK mRNA in particular regions (hippocampus, periaqueductal grey and thalamus) of the rat by in situ hybridization. Neuroscience Letters, 104, 38-42.
41. Lines, C., Challenor, J., & Traub, M. (1995). Cholecystokinin and anxiety in normal volunteers: An investigation of the anxiogenic properties of pentagastrin and reversal by the cholecystokinin receptor subtype B antagonist L-365, 260. British Journal of Clinical Pharmacology, 39, 235-242.
42. Liu, H., Chandler, S., Beitz, A. J., Shipley, M. T., & Behbehani, M. M. (1994). Characterization of the effect of cholecystokinin (CCK) on neurons in the periaqueductal gray of the rat: Immunocytochemical and in vivo and in vitro electrophysiological studies. Brain Research, 642, 83-94.
43. Malenka, R. C., & Nicoll, R. A. (1993). NMDA-receptor-dependent synaptic plasticity: Multiple forms and mechanisms. Trends in Neurosciences, 16, 521-527.
44. Mardia, K. V. (1970). Measures of multivariate skewness and kurtosis with applications. Biometrika, 57, 519-530.
45. McCullough, L. D., & Salamone, J. D. (1992). Anxiogenic drugs beta-CCE and FG 7142 increase extracellular dopamine levels in nucleus accumbens. Psychopharmacology, 109, 379-382.
46. Nashold, B. S., Jr., Wilson, N. P., & Slaughter, G. S. (1969). Sensations evoked by stimulation in the midbrain of man. Journal of Neurosurgery, 30, 14-24.
47. Nashold, B. S., Jr., Wilson, N. P., & Slaughter, G. S. (1974). The midbrain and pain. In J. J. Bonica (Ed.), Advances in neurology: Vol. 4. International symposium on pain (pp. 191-196). New York: Raven Press.
48. Pavlasevic, S., Bednar, I., Qureshi, G. A., & Södersten, P. (1993). Brain cholecystokinin tetrapeptide levels are increased in a rat model of anxiety. NeuroReport, 5, 225-228.
49. Pitman, R. K., Orr, S. P., & Shalev, A. Y. (1993). Once bitten, twice shy: Beyond the conditioning model of PTSD. Biological Psychiatry, 33, 145-146.
50. Pratt, J. A., & Brett, R. R. (1995). The benzodiazepine receptor inverse agonist FG 7142 induces cholecystokinin gene expression in rat brain. Neuroscience Letters, 184, 197-200.
51. Rasmussen, K., Helton, D. R., Berger, J. E., & Scearce, E. (1993). The CCK-B antagonist LY288513 blocks effects of diazepam withdrawal on auditory startle. NeuroReport, 5, 154-156.
52. Rasmussen, K., Helton, D. R., Berger, J. E., & Scearce, E. (1994). The CCK-B antagonist LY288513 blocks diazepam-withdrawal-induced increases in auditory startle response. Annals of the New York Academy of Sciences, 713, 374-376.
53. Rataud, J., Darche, F., Piot, O., Stutzmann, J.-M., Böhme, G. A., & Blanchard, J.-C. (1991). Anxiolytic effect of CCK-antagonists on plus-maze behavior in mice. Brain Research, 548, 315-317.
54. 3H]cholecystokinin in the ventromedial hypothalamus is modulated by an afferent brainstem projection but not by ovarian steroids. Brain Research, 564, 102-108.
55. Shaikh, M. B., Steinberg, A., & Siegel, A. (1993). Evidence that substance P is utilized in medial amygdaloid facilitation of defensive rage behavior in the cat. Brain Research, 625, 283-294.
56. A receptor agonist. Behavioral and Neural Biology, 57, 226-232.
57. Singh, L., Lewis, A. S., Field, M. J., Hughes, J., & Woodruff, G. N. (1991). Evidence for an involvement of the brain cholecystokinin B receptor in anxiety. Proceedings of the National Academy of Sciences USA, 88, 1130-1133.
58. Speed, N., Engdahl, B., Schwartz, J., & Eberly, R. (1989). Posttraumatic stress disorder as a consequence of the POW experience. Journal of Nervous and Mental Disorders, 177, 273-289.
59. Treit, D., Menard, J., & Royan, C. (1993). Anxiogenic stimuli in the elevated plus-maze. Pharmacology, Biochemistry and Behavior, 44, 463-469.
60. Van der Kolk, B. A. (1994. January/February). The body keeps the score: Memory and the evolving psychobiology of posttraumatic stress disorder. Harvard Review of Psychiatry, 253-265.
61. Verbalis, J. G., Stricken E. M., Robinson, A. G., & Hoffman, G. E. (1991). Cholecystokinin activates C-fos expression in hypothalamic oxytocin and corticotropin-releasing hormone neurons. Journal of Neuroendocrinology, 3, 205-213.
62. B-receptor activation augments the long-term potentiation in guinea pig hippocampal slices. Japanese Journal of Pharmacology, 68, 441-447.
63. Zangrossi, H., Jr., & File, S. E. (1992). Behavioral consequences in animal tests of anxiety and exploration of exposure to cat odor. Brain Research Bulletin, 29, 381-388.
64. Zangrossi, H., Jr., & File, S. E. (1994). Habituation and generalization of phobic responses to cat odor. Brain Research Bulletin, 33, 189-194.